Edwards Lifesciences at PCR London Valves 2022

Sunday 27 November - 17:30-19:00 (UK time) - Main Arena

Therapy of valvular heart diseases: a patient-centred innovation journey

Join this program if you want:

  • To explore how patients have historically been at the centre of technological development for the unmet needs of treating valvular heart disease
  • To discuss how innovations enable increasingly sophisticated treatment options that an interdisciplinary heart team can tailor to the needs of each patient against the background of a comprehensive lifetime management
  • To deliberate the therapeutic options that are available for patients with progressive or multivalvular heart diseases
Register now


Prof. Bernard Prendergast
St Thomas' Hospital – London, United Kingdom
Prof. Joerg Kempfert
German Heart Centre – Berlin, Germany
Dr. Philippe Genereux
Morristown Medical Center’s – New York, USA
Dr. Victoria Delgado
University Hospital Germans Trias i Pujol - Barcelona, Spain
Procedural analyst
Prof. Augusto D’Onofrio
University Hospital of Padua - Italy
First speaker
Prof. Helene Eltchaninoff
University Hospital of Rouen - France
Second speaker
Prof. Fabien Praz
Bern University Hospital - Switzerland
Third speaker
Tuesday 29 November - 11:05-12:35 (UK time) - Room 2

TAVI-in-TAVI - A road map for successful lifetime management

Join this program if you want:

  • To learn that the choice of the first TAVI is crucial when planning the lifetime management of a patient as it has a significant impact on treatment options in the future
  • To understand the challenges that make re-do TAVI so special (so different from TAVI in surgical aortic valve replacement or in native aortic stenosis)
  • To familiarise with a strategy that guides operators through different technical scenarios for the best possible outcomes
Register now


Prof. Hendrik Treede
Heart and Vascular Center - Mainz, Germany
Dr. Daniel Blackman
Yorkshire Heart Centre
Dr. Victoria Delgado
University Hospital Germans Trias i Pujol - Barcelona, Spain
Prof. Giuseppe Tarantini
University Hospital of Padua – Padova, Italy
First speaker
Dr. Janarthanan Sathananthan
Vancouver General and St Paul’s
Second speaker
Dr. Francesco Saia
University Hospital of Bologna
Third speaker
Dr. Radoslaw Parma
Medical University of Silesia – Katowice, Poland
Fourth speaker
Prof. Ole de Backer
Rigshospitalet, Copenhagen
Fifth speaker

Sign up now to receive copies of Edwards Lifesciences recorded event sessions post event, as well as receive event and news informations from Edwards Lifesciences, including:


Featuring the latest cardiology news, clinical trials and real-world evidence in aortic stenosis (AS) management.

Panel discussions

Involving leading cardiologists debating the latest topics in transcatheter aortic valve implantation (TAVI) and AS management.

Conference headlines

Providing insights into the major developments from the latest cardiology events.

Guidelines updates

Highlighting the areas of change within any updated aortic stenosis treatment guidelines.

Medical device for professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).

PP--EU-5445 v1.0